As ONE’s fiscal year ending March 2026 resulted in record-high sales of 110.6 billion yen (+6.7% YoY) and operating profit of 12.8 billion yen (+10.7%), maintaining steady performance driven by post-COVID medical and research demand.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7476","jir_company_name":"As ONE Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-05-22","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/7476-20260522-01.pdf","jir_short_summary":"As ONE's fiscal year ending March 2026 resulted in record-high sales of 110.6 billion yen (+6.7% YoY) and operating profit of 12.8 billion yen (+10.7%), maintaining steady performance driven by post-COVID medical and research demand.","jir_summary":"### Performance Overview\nAs ONE's fiscal year ending March 2026 achieved record-high sales of 110.6 billion yen (YoY +6.7%) and operating profit of 12.8 billion yen (+10.7%), reflecting steady growth driven by expanding demand in medical and research fields, with a continued recovery trend post-COVID. The increase in sales was primarily due to strong performance in research equipment and medical-related products, with improved profit margins.\n\n### Outlook and Investor Impact\nLooking ahead, sustained growth is expected backed by expanding demand in medical and research sectors. The company is actively advancing new businesses and international expansion, promising medium- to long-term growth. For investors, the company offers a stable earnings base and growth potential, with prospects for stock price appreciation and increased dividends.","jir_financial_highlights":"Sales: 110.6 billion yen (YoY +6.7%)\nOperating profit: 12.8 billion yen (YoY +10.7%)\nNet income: 9.179 billion yen (YoY +11.5%)","jir_category":"","jir_hashtags":"#AsONE, #FinancialResults, #JapaneseStocks","jir_key_figures":"Sales: 110.6 billion yen (YoY +6.7%)\nOperating profit: 12.8 billion yen (YoY +10.7%)\nNet income: 9.179 billion yen (YoY +11.5%)","jir_meta_title":"\u3010As ONE\u3011Fiscal Year Ending March 2026 Financial Results | Sales of 110.6 billion yen (+6.7%)","jir_meta_description":"As ONE's fiscal year ending March 2026 reports sales of 110.6 billion yen, reaching all-time highs. Sustained growth driven by expanding medical and research demand, highlighting strong investment appeal.","jir_og_title":"\u3010As ONE\u3011Fiscal Year Ending March 2026 Financial Results | Sales of 110.6 billion yen (+6.7%)","jir_og_description":"As ONE's earnings hit record highs in sales and profits. Growing demand in healthcare and research sectors supports continued growth prospects.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Sales Trends\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2022\/3\\\", \\\"2023\/3\\\", \\\"2024\/3\\\", \\\"2025\/3\\\", \\\"2026\/3\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Sales (Billion Yen)\\\", \\\"data\\\": [1125, 1078, 1090, 1040, 1106], \\\"borderColor\\\": \\\"#36A2EB\\\", \\\"fill\\\": false}]}\\\"\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Profit Trends\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2022\/3\\\", \\\"2023\/3\\\", \\\"2024\/3\\\", \\\"2025\/3\\\", \\\"2026\/3\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Operating Profit (Billion Yen)\\\", \\\"data\\\": [110, 118, 122, 116, 128], \\\"borderColor\\\": \\\"#4BC0C0\\\", \\\"fill\\\": false}]}\\\"\"}, {\"jir_chart_id\": \"profit_margin\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Profit Margin Trends\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2022\/3\\\", \\\"2023\/3\\\", \\\"2024\/3\\\", \\\"2025\/3\\\", \\\"2026\/3\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Operating Margin (%)\\\", \\\"data\\\": [9.8, 10.9, 11.2, 11.6, 11.7], \\\"borderColor\\\": \\\"#FF6384\\\", \\\"fill\\\": false}]}\\\"\"}]","ir_related_company":9038,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-53879","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n